D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.76% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NKLA
3201
CALL
DELISTED
Nikola Corporation Common Stock
NKLA
| $717K | ﹤0.01% |
27,333
| – | – |
|
3202
MGM Resorts International
MGM
$11.8B
| $713K | ﹤0.01% |
15,953
-235,586
| -94% | -$9.24M |
|
3203
Invesco S&P 500 Pure Growth ETF
RPG
$2.02B
| $713K | ﹤0.01% |
+22,088
| New | +$676K |
|
3204
Willdan Group
WLDN
$1.09B
| $712K | ﹤0.01% |
33,111
+2,766
| +9% | +$55K |
|
|
JKS
3205
JinkoSolar
JKS
$799M
| $711K | ﹤0.01% |
19,255
-65,788
| -77% | -$2.12M |
|
3206
Nabors Industries
NBR
$1.16B
| $709K | ﹤0.01% |
8,686
-13,539
| -61% | -$1.31M |
|
3207
ALPS Clean Energy ETF
ACES
$110M
| $708K | ﹤0.01% |
+19,718
| New | +$640K |
|
3208
Dr. Reddy's Laboratories
RDY
$9.8B
| $707K | ﹤0.01% |
+50,790
| New | +$679K |
|
3209
Quanex
NX
$863M
| $707K | ﹤0.01% |
23,111
-12,148
| -34% | -$358K |
|
|
JMIA
3210
PUT
Jumia Technologies
JMIA
$752M
| $706K | ﹤0.01% |
200,000
| – | – |
|
3211
Lennar Class B
LEN.B
$20.1B
| $705K | ﹤0.01% |
5,530
-11,156
| -67% | -$1.21M |
|
3212
Citizens Financial Group
CFG
$30.1B
| $704K | ﹤0.01% |
21,257
-75,237
| -78% | -$2.07M |
|
|
XHR
3213
Xenia Hotels & Resorts
XHR
$2B
| $703K | ﹤0.01% |
51,621
-134,906
| -72% | -$1.66M |
|
3214
Eagle Materials
EXP
$6.69B
| $700K | ﹤0.01% |
3,451
+1,900
| +123% | +$334K |
|
3215
Invesco WilderHill Clean Energy ETF
PBW
$409M
| $700K | ﹤0.01% |
+23,548
| New | +$650K |
|
3216
Smith & Wesson
SWBI
$666M
| $697K | ﹤0.01% |
51,379
| – | – |
|
3217
CALL
Flywire
FLYW
$1.99B
| $695K | ﹤0.01% |
+30,000
| New | +$757K |
|
|
JMIA
3218
Jumia Technologies
JMIA
$752M
| $694K | ﹤0.01% |
196,588
-218,834
| -53% | -$658K |
|
3219
Avita Medical
RCEL
$146M
| $694K | ﹤0.01% |
50,556
-3,060
| -6% | -$35.1K |
|
3220
Houlihan Lokey
HLI
$9.75B
| $689K | ﹤0.01% |
5,749
-9,149
| -61% | -$992K |
|
3221
Vanguard Financials ETF
VFH
$13.5B
| $685K | ﹤0.01% |
+7,428
| New | +$624K |
|
3222
Dine Brands
DIN
$448M
| $683K | ﹤0.01% |
13,751
-17,465
| -56% | -$829K |
|
3223
Copa Holdings
CPA
$5.65B
| $683K | ﹤0.01% |
6,422
-207,052
| -97% | -$18.9M |
|
3224
PUT
Chegg
CHGG
$110M
| $682K | ﹤0.01% |
60,000
| – | – |
|
3225
Cadeler
CDLR
$2.16B
| $681K | ﹤0.01% |
+37,014
| New | +$666K |
|
Similar funds
D.E. Shaw & Co's Q4 2023 Portfolio in Review
As of Q4 2023, D.E. Shaw & Co held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- D.E. Shaw & Co added most to Netflix in Q4 2023, an estimated $751M increase.
- D.E. Shaw & Co's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- D.E. Shaw & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- D.E. Shaw & Co opened 575 new positions and closed 527 in Q4 2023.
- D.E. Shaw & Co's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.